Literature DB >> 10199528

Procalcitonin used as a marker of infection in the intensive care unit.

H Ugarte1, E Silva, D Mercan, A De Mendonça, J L Vincent.   

Abstract

OBJECTIVE: To determine the value of procalcitonin (ProCT) as a marker of infection in critically ill patients.
DESIGN: Prospective, observational study.
SETTING: Medicosurgical department of intensive care (31 beds). PATIENTS: One hundred eleven infected and 79 noninfected patients.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: ProCT and C-reactive protein (CRP) concentrations were monitored daily. The best cutoff values for ProCT and CRP were 0.6 ng/mL and 7.9 mg/dL, respectively. Compared with CRP, ProCT had a lower sensitivity (67.6 vs. 71.8), specificity (61.3 vs. 66.6), and area under the receiver operating characteristic curve (0.66 vs. 0.78, p < .05). The combination of ProCT and CRP increased the specificity for infection to 82.3%. In the infected patients, plasma ProCT, but not CRP, values were higher in nonsurvivors than in survivors. Infected patients with bacteremia had higher ProCT concentrations than those without bacteremia, but similar CRP concentrations. ProCT levels were particularly high in septic shock patients.
CONCLUSIONS: ProCT is not a better marker of infection than CRP in critically ill patients, but it can represent a useful adjunctive parameter to identify infection and is a useful marker of the severity of infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199528     DOI: 10.1097/00003246-199903000-00024

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  96 in total

1.  Biomarkers of sepsis: is procalcitonin ready for prime time?

Authors:  Jérôme Pugin
Journal:  Intensive Care Med       Date:  2002-09       Impact factor: 17.440

2.  In vivo demonstration of neuroinflammatory molecule expression in brain abscess with diffusion tensor imaging.

Authors:  R K Gupta; K Nath; A Prasad; K N Prasad; M Husain; R K S Rathore; N Husain; C Srivastava; P Khetan; R Trivedi; P A Narayana
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

3.  Procalcitonin for antibiotic treatment in intensive care unit patients.

Authors:  Nathalie Layios; Bernard Lambermont
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

4.  Procalcitonin and acute coronary syndromes: a new biomarker for an old disease.

Authors:  Luigi M Biasucci; Gina Biasillo; Antonella Stefanelli
Journal:  Intern Emerg Med       Date:  2009-07-29       Impact factor: 3.397

Review 5.  Clinical sepsis and septic shock--definition, diagnosis and management principles.

Authors:  Jean-Louis Vincent
Journal:  Langenbecks Arch Surg       Date:  2008-06-27       Impact factor: 3.445

6.  Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock.

Authors:  Y Heper; E H Akalin; R Mistik; S Akgöz; O Töre; G Göral; B Oral; F Budak; S Helvaci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

7.  Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.

Authors:  Pierre Emmanuel Charles; Frédéric Dalle; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Hervé Aube; Nils-Olivier Olsson; Bernard Blettery
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

Review 8.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

9.  Coagulase-negative Staphylococcus, catheter-related, bloodstream infections and their association with acute phase markers of inflammation in the intensive care unit: An observational study.

Authors:  Oleksa Rewa; John Muscedere; Steve Reynolds; Xuran Jiang; Daren K Heyland
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

10.  Serum and pleural fluid procalcitonin in predicting bacterial infection in patients with parapneumonic effusion.

Authors:  Yang-Ching Ko; Wen-Pin Wu; Chi-Sen Hsu; Mong-Ping Dai; Chien-Chih Ou; Chih-Hsiung Kao
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.